Importantly, in addition to promoting tumor cell regrowth, caspase-3 stimulated PGE2 release contributes to epithelial–mesenchymal transition (EMT), anti-cancer immunity, and therapeutic resistance (Tong et al., 2018). Here, CASP3 is linked to neoplasm.